Publications for Magdy El-Salhy
Co-author map based on ISI articles 2007-

Keywords

viable vessels tumours tumour triple treatment serotonin proliferation octreotide mice ip implanted galanin double colon cells cancer blood apoptosis animals

Journal Articles

Jussi Rauma, Anna Spångéus and Magdy El-Salhy
  Ghrelin cell density in the gastrointestinal tracts of animal models of human diabetes.
  Histology and Histopathology, 2006, 21(1), 1-5.
 Web of Science® Times Cited: 9

Magdy El-Salhy
  Combined treatment with octreotide, Galanin and serotonin in gastrointestinal malignancies
  Letters in Drug Design & Discovery, 2005, 2(6), 439-443.

Magdy El-Salhy
  Triple treatment with octreotide, galanin and serotonin is a promising therapy for colorectal cancer
  Current pharmaceutical design, 2005, 11(16), 2107-2117.
 Web of Science® Times Cited: 11

Magdy El-Salhy, L Hilding, H Royson and Veronica Tjomsland
  Comparison between triple therapy with octreotide, galanin and serotonin vs. irinotecan or oxaliplatin in combination with 5-fluorouracil/leukovorin in human colon cancer.
  International Journal of Oncology, 2005, 27(3), 687-691.
 Web of Science® Times Cited: 7

Veronica Tjomsland and Magdy El-Salhy
  Anti-tumour effects of triple therapy with octreotide, galanin and serotonin in comparison with those of 5-fluorouracil/leukovorin on human colon cancer.
  International Journal of Oncology, 2005, 27(2), 427-432.
 Web of Science® Times Cited: 4

Magdy El-Salhy
  Effects of triple therapy with octreotide, galanin and serotonin on a human colon cancer cell line implanted in mice: Comparison between different routes of administration
  Histology and Histopathology, 2005, 20(1), 19-25.
 Web of Science® Times Cited: 6

Vegard Tjomsland and Magdy El-Salhy
  Effects of single, double or triple combinations of octreotide, galanin and serotonin on a human pancreatic cancer cell line
  Histology and Histopathology, 2005, 20(2), 537-541.
 Web of Science® Times Cited: 5

Magdy El-Salhy
  Effects of octreotide, galanin and serotonin on a human gastric cancer cell line.
  Oncology Reports, 2005, 13(5), 787-791.
 Web of Science® Times Cited: 4

Magdy El-Salhy, Vegard Tjomsland and Elvar Theodorsson
  Effects of triple treatment with octreotide, galanin and serotonin on a human pancreas cancer cell line in xenografts
  Histology and Histopathology, 2005, 20(3), 745-752.
 Web of Science® Times Cited: 4

Magdy El-Salhy
  Effects of triple therapy with octreotide, galanin and serotonin on a human colon cancer cell line.
  Oncology Reports, 2005, 13(1), 45-49.
 Web of Science® Times Cited: 2

Magdy El-Salhy
  Comparison between triple therapy with octreotide, galanin and serotonin, 5-fluorouracil/leucovorin, and sequential treatment with both, on human colon cancer.
  Oncology Reports, 2004, 11(6), 1161-1168.
 Web of Science® Times Cited: 7

Magdy El-Salhy and Veronica Dennerqvist
  Effects of triple therapy with octreotide, galanin and serotonin on liver metastasis of human colon cancer in xenografts.
  Oncology Reports, 2004, 11(6), 1177-1182.
 Web of Science® Times Cited: 14

Magdy El-Salhy and Anna Starefeldt
  Direct effects of octreotide, galanin and serotonin on human colon cancer cells.
  Oncology Reports, 2003, 10, 1723-1728.

Magdy El-Salhy, Basel Sitohy and Örjan Norrgård
  Triple therapy with octreotide, galanin, and serotonin reduces the size and blood vessel density and increases apoptosis of a rat colon carcinoma.
  Regulatory Peptides, 2003, 111, 145-152.

B Sitohy and Magdy El-Salhy
  A comparison between double and triple therapies of octreotide, galanin and serotonin on a rat colon carcinoma.
  Histology and Histopathology, 2003, 18, 103-110.

Magdy El-Salhy
  Chronic idiopathic slow transit constipation: pathophysiology and management.
  Colorectal Disease, 2003, 5, 288-296.

Books

Magdy El-Salhy
  Neuroendocrine Immune Network in Ageing
  , 2004.